drug protocol number

H19-940

drug sponsor

Abbvie

drug study

Drug choice as per treating physician which is not limited per the protocol

drug trial site

Hira Hospital (Makkah), Security Force Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase